This article is more than 5 years old. Information may no longer be current.

VIDEO: Oral treatment shows good visual improvement in newly diagnosed wet AMD patients

Issue: April 25, 2019

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

FORT LAUDERDALE, Fla. — At the Retina World Congress, Michael W. Stewart, MD, professor and chairman of ophthalmology at the Mayo Clinic in Jacksonville, Florida, discusses first results of a phase 2a study of ALK4290 (Alkahest), now known as AKST4290, for the treatment of patients with newly diagnosed wet age-related macular degeneration.